Adherence to Anticholinergic Therapy and Clean Intermittent Self-Catheterization in Patients With Multiple Sclerosis

Overview

Journal Int Neurourol J

Date 2018 Jul 12

PMID 29991235

Citations 5

Authors

Damien Motavasseli

Camille Chesnel

Audrey Charlanes

Diane Menoux

Francis Charoenwong

Frederique Le Breton

Gerard Amarenco

Affiliations

Soon will be listed here.

Abstract

Purpose: To evaluate adherence to anticholinergic therapy (AT) and clean intermittent self-catheterization (CISC) in patients with multiple sclerosis (MS) and to identify factors associated with poor adherence.

Methods: This single-center study prospectively included 49 patients suffering from MS who had been prescribed AT and/or CISC. Adherence was evaluated using a self-report questionnaire. The Expanded Disability Status Scale (EDSS), Patient Global Impression of Improvement, Mini-Mental State Examination, Urinary Symptom Profile, and Hospital Anxiety and Depression (HAD) instruments were administered, and the number of daily anticholinergic pills and/or catheterizations was noted. Whether patients were receiving concomitant intradetrusor botulinum toxin injections was assessed, as were barriers to treatment, side effects, number of spontaneous micturitions, reasons for the prescription, satisfaction, and difficulties.

Results: Only 38% of patients were adherent to AT. Experiencing side effects was related to nonadherence (P=0.02). Only 29% of patients were adherent to CISC. More intense voiding dysfunction (P<0.001), a higher frequency of CISC (P=0.03), and a higher EDSS score (P=0.02) were associated with better adherence. Conversely, the HAD score (P<0.001), depression (P<0.001), the persistence of spontaneous micturition (P<0.001), a blocking sensation during catheterization (P=0.04), and the need to adapt one's posture or gesture to perform catheterization (P=0.04) were associated with poorer adherence.

Conclusions: Adherence to AT and CISC was poor in patients with MS suffering from bladder dysfunction. Several factors related to nonadherence were identified in this study, and addressing these factors might help to improve treatment adherence.

Citing Articles

Evolution of Quality of Life and Treatment Adherence after One Year of Intermittent Bladder Catheterisation in Functional Urology Unit Patients.

Fernandez-Lasquetty Blanc B, Martinez A, Lorenzo Garcia C, Baixauli Puig M, Estudillo Gonzalez F, Martin Bermejo M J Clin Med. 2023; 12(8).

PMID: 37109264 PMC: 10145256. DOI: 10.3390/jcm12082928.

Quality of Life and Autonomy in Patients with Intermittent Bladder Catheterization Trained by Specialized Nurses.

Fernandez-Lasquetty Blanc B, Rodriguez-Almagro J, Lorenzo-Garcia C, Alcaraz-Zomeno E, Fernandez-Llorente G, Baixauli-Puig M J Clin Med. 2021; 10(17).

PMID: 34501357 PMC: 8432259. DOI: 10.3390/jcm10173909.

Rehabilitation Before and After Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Patients With Multiple Sclerosis (MS): Consensus Guidelines and Recommendations for Best Clinical Practice on Behalf of the Autoimmune Diseases Working....

Roberts F, Hobbs H, Jessop H, Bozzolini C, Burman J, Greco R Front Neurol. 2020; 11:556141.

PMID: 33362684 PMC: 7759663. DOI: 10.3389/fneur.2020.556141.

Use of a symptom-based questionnaire to screen for the presence of significant voiding dysfunction in patients with multiple sclerosis and lower urinary tract symptoms: a pilot study.

Li V, Panicker J, Haslam C, Chataway J J Neurol. 2020; 267(12):3683-3688.

PMID: 32671529 PMC: 7674358. DOI: 10.1007/s00415-020-10068-2.

Autologous haematopoietic stem cell therapy for multiple sclerosis: a review for supportive care clinicians on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation.

Ismail A, Sharrack B, Saccardi R, Moore J, Snowden J Curr Opin Support Palliat Care. 2019; 13(4):394-401.

PMID: 31599815 PMC: 6867671. DOI: 10.1097/SPC.0000000000000466.

References

Costello K, Kennedy P, Scanzillo J . Recognizing nonadherence in patients with multiple sclerosis and maintaining treatment adherence in the long term. Medscape J Med. 2008; 10(9):225. PMC: 2580090. View

Vahter L, Zopp I, Kreegipuu M, Kool P, Talvik T, Gross-Paju K . Clean intermittent self-catheterization in persons with multiple sclerosis: the influence of cognitive dysfunction. Mult Scler. 2008; 15(3):379-84. DOI: 10.1177/1352458508098599. View

Seth J, Haslam C, Panicker J . Ensuring patient adherence to clean intermittent self-catheterization. Patient Prefer Adherence. 2014; 8:191-8. PMC: 3928402. DOI: 10.2147/PPA.S49060. View

Yalcin I, Bump R . Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol. 2003; 189(1):98-101. DOI: 10.1067/mob.2003.379. View

Kessler T, Ryu G, Burkhard F . Clean intermittent self-catheterization: a burden for the patient?. Neurourol Urodyn. 2008; 28(1):18-21. DOI: 10.1002/nau.20610. View

Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U . The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002; 21(2):167-78. DOI: 10.1002/nau.10052. View

Gellad W, Grenard J, Marcum Z . A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother. 2011; 9(1):11-23. PMC: 3084587. DOI: 10.1016/j.amjopharm.2011.02.004. View

van Achterberg T, Holleman G, Cobussen-Boekhorst H, Arts R, Heesakkers J . Adherence to clean intermittent self-catheterization procedures: determinants explored. J Clin Nurs. 2007; 17(3):394-402. DOI: 10.1111/j.1365-2702.2006.01893.x. View

Sexton C, Notte S, Maroulis C, Dmochowski R, Cardozo L, Subramanian D . Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature. Int J Clin Pract. 2011; 65(5):567-85. DOI: 10.1111/j.1742-1241.2010.02626.x. View

10.

Vrijens B, Urquhart J . Patient adherence to prescribed antimicrobial drug dosing regimens. J Antimicrob Chemother. 2005; 55(5):616-27. DOI: 10.1093/jac/dki066. View

11.

Bolinger R, Engberg S . Barriers, complications, adherence, and self-reported quality of life for people using clean intermittent catheterization. J Wound Ostomy Continence Nurs. 2012; 40(1):83-9. DOI: 10.1097/WON.0b013e3182750117. View

12.

Guinet-Lacoste A, Jousse M, Verollet D, Sheikh Ismael S, Le Breton F, Tan E . Validation of the InCaSaQ, a new tool for the evaluation of patient satisfaction with clean intermittent self-catheterization. Ann Phys Rehabil Med. 2014; 57(3):159-68. DOI: 10.1016/j.rehab.2014.02.007. View

13.

Balkrishnan R, Bhosle M, Camacho F, Anderson R . Predictors of medication adherence and associated health care costs in an older population with overactive bladder syndrome: a longitudinal cohort study. J Urol. 2006; 175(3 Pt 1):1067-71. DOI: 10.1016/S0022-5347(05)00352-6. View

14.

Morisky D, Ang A, Krousel-Wood M, Ward H . Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008; 10(5):348-54. PMC: 2562622. DOI: 10.1111/j.1751-7176.2008.07572.x. View

15.

Dasgupta R, Fowler C . Bladder, bowel and sexual dysfunction in multiple sclerosis: management strategies. Drugs. 2003; 63(2):153-66. DOI: 10.2165/00003495-200363020-00003. View

16.

Monane M, Bohn R, Gurwitz J, Glynn R, Levin R, Avorn J . The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens. 1997; 10(7 Pt 1):697-704. DOI: 10.1016/s0895-7061(97)00056-3. View

17.

Dias Barbosa C, Balp M, Kulich K, Germain N, Rofail D . A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence. Patient Prefer Adherence. 2012; 6:39-48. PMC: 3262489. DOI: 10.2147/PPA.S24752. View

18.

Amarenco G, Guinet A, Jousse M, Verollet D, Ismael S . Pencil and paper test: a new tool to predict the ability of neurological patients to practice clean intermittent self-catheterization. J Urol. 2010; 185(2):578-82. DOI: 10.1016/j.juro.2010.09.106. View

19.

Bruce J, Hancock L, Arnett P, Lynch S . Treatment adherence in multiple sclerosis: association with emotional status, personality, and cognition. J Behav Med. 2010; 33(3):219-27. DOI: 10.1007/s10865-010-9247-y. View

20.

Gomelsky A, Dmochowski R . Update on the management of overactive bladder: patient considerations and adherence. Open Access J Urol. 2013; 3:7-17. PMC: 3818931. DOI: 10.2147/OAJU.S7233. View